{"id":740726,"date":"2023-03-16T08:59:04","date_gmt":"2023-03-16T12:59:04","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/neurostar-advanced-therapy-receives-patient-impact-award-from-life-sciences-pa\/"},"modified":"2023-03-16T08:59:04","modified_gmt":"2023-03-16T12:59:04","slug":"neurostar-advanced-therapy-receives-patient-impact-award-from-life-sciences-pa","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/neurostar-advanced-therapy-receives-patient-impact-award-from-life-sciences-pa\/","title":{"rendered":"NeuroStar\u00ae Advanced Therapy Receives Patient Impact Award from Life Sciences PA"},"content":{"rendered":"

\nAward recognizes NeuroStar for its significant contributions toward patient wellbeing
\n<\/h2>\n
\n

MALVERN, Pa., March 16, 2023 (GLOBE NEWSWIRE) — Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohealth disorders, is named a recipient of Life Sciences Pennsylvania\u2019s (LSPA) annual\u00a0Patient Impact Award\u00a0for 2022.<\/p>\n

\u201cWe are honored that Life Sciences Pennsylvania has identified NeuroStar as a recipient of the Patient Impact Award,\u201d said Keith J. Sullivan, President and CEO of Neuronetics. \u201cWe take pride in positively impacting the lives of individuals suffering from depression and other mental health conditions. We believe they deserve a safe, effective, and non-invasive treatment option when traditional antidepressant medications don\u2019t work.\u201d<\/p>\n

The Patient Impact Award acknowledges the outstanding efforts of a medicine, therapy, device, or organization that has significantly improved healthcare quality to achieve better patient outcomes in 2022. LSPA aims to establish Pennsylvania as a leading state in the life sciences industry by advocating for public policies that support the growth and success of the life sciences ecosystem and by fostering connections between individuals and resources within the industry.<\/p>\n

\u201cBy choosing Neuronetics as a recipient of our annual Patient Impact Award, we are honoring their unwavering dedication to improving the lives of those struggling with mental health conditions,\u201d stated Christopher P. Molineaux, President and CEO of Life Sciences Pennsylvania. \u201cNeuroStar\u2019s innovative technology and patient-centric approach have helped to revolutionize the field of neuromodulation, and we are proud to recognize their significant contributions to improving patient care.\u201d<\/p>\n

NeuroStar is the leading FDA-cleared and non-invasive transcranial magnetic stimulation (TMS) treatment for depression in adults, with over 5.3 million treatment sessions performed in over 147,000 patients. The full list of award honorees can be found here<\/a>. For more information about NeuroStar, please visit\u00a0neurostar.com<\/a>.<\/p>\n

\n
\n
About<\/strong>
\n Neuronetics
<\/strong>Neuronetics, Inc.\u00a0believes that mental health is as important as physical health. As a global leader in neuroscience,\u00a0Neuronetics\u00a0is redefining patient and physician expectations with its NeuroStar Advanced Therapy for Mental Health. NeuroStar is a non-drug, noninvasive treatment that can improve the quality of life for people suffering from neurohealth conditions when traditional medication hasn\u2019t helped. NeuroStar is FDA-cleared for adults with major depressive disorder (MDD), as an adjunct for adults with obsessive-compulsive disorder (OCD), and to decrease anxiety symptoms in adult patients with MDD that may exhibit comorbid anxiety symptoms (anxious depression). NeuroStar Advanced Therapy is the leading transcranial magnetic stimulation (TMS) treatment for MDD in adults with over 5.3 million treatments delivered. NeuroStar is backed by the largest clinical data set of any TMS system for depression, including the world\u2019s largest depression Outcomes Registry.\u00a0Neuronetics\u00a0is committed to transforming lives by offering an exceptional treatment that produces extraordinary results. For safety and prescribing information,\u00a0www.neurostar.com<\/strong><\/a>.<\/p>\n

\n Media Contact:<\/strong>
\n
EvolveMKD
646.517.4220
NeuroStar@evolvemkd.com<\/a><\/p>\n<\/p>\n


\n
\n \n <\/div>\n

<\/div>\n","protected":false},"excerpt":{"rendered":"

Award recognizes NeuroStar for its significant contributions toward patient wellbeing MALVERN, Pa., March 16, 2023 (GLOBE NEWSWIRE) — Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohealth disorders, is named a recipient of Life Sciences Pennsylvania\u2019s (LSPA) annual\u00a0Patient Impact Award\u00a0for 2022. \u201cWe are honored that Life Sciences Pennsylvania has identified NeuroStar as a recipient of the Patient Impact Award,\u201d said Keith J. Sullivan, President and CEO of Neuronetics. \u201cWe take pride in positively impacting the lives of individuals suffering from depression and other mental health conditions. We believe they deserve a safe, effective, and non-invasive treatment option when traditional antidepressant … <\/p>\n

Continue reading “NeuroStar\u00ae Advanced Therapy Receives Patient Impact Award from Life Sciences PA”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-740726","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nNeuroStar\u00ae Advanced Therapy Receives Patient Impact Award from Life Sciences PA - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/neurostar-advanced-therapy-receives-patient-impact-award-from-life-sciences-pa\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"NeuroStar\u00ae Advanced Therapy Receives Patient Impact Award from Life Sciences PA - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Award recognizes NeuroStar for its significant contributions toward patient wellbeing MALVERN, Pa., March 16, 2023 (GLOBE NEWSWIRE) — Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohealth disorders, is named a recipient of Life Sciences Pennsylvania\u2019s (LSPA) annual\u00a0Patient Impact Award\u00a0for 2022. \u201cWe are honored that Life Sciences Pennsylvania has identified NeuroStar as a recipient of the Patient Impact Award,\u201d said Keith J. Sullivan, President and CEO of Neuronetics. \u201cWe take pride in positively impacting the lives of individuals suffering from depression and other mental health conditions. We believe they deserve a safe, effective, and non-invasive treatment option when traditional antidepressant … Continue reading "NeuroStar\u00ae Advanced Therapy Receives Patient Impact Award from Life Sciences PA"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/neurostar-advanced-therapy-receives-patient-impact-award-from-life-sciences-pa\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2023-03-16T12:59:04+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc4OTI5NSM1NDY0NzM1IzIxMTA0NDA=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/neurostar-advanced-therapy-receives-patient-impact-award-from-life-sciences-pa\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/neurostar-advanced-therapy-receives-patient-impact-award-from-life-sciences-pa\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"NeuroStar\u00ae Advanced Therapy Receives Patient Impact Award from Life Sciences PA\",\"datePublished\":\"2023-03-16T12:59:04+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/neurostar-advanced-therapy-receives-patient-impact-award-from-life-sciences-pa\\\/\"},\"wordCount\":484,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/neurostar-advanced-therapy-receives-patient-impact-award-from-life-sciences-pa\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODc4OTI5NSM1NDY0NzM1IzIxMTA0NDA=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/neurostar-advanced-therapy-receives-patient-impact-award-from-life-sciences-pa\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/neurostar-advanced-therapy-receives-patient-impact-award-from-life-sciences-pa\\\/\",\"name\":\"NeuroStar\u00ae Advanced Therapy Receives Patient Impact Award from Life Sciences PA - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/neurostar-advanced-therapy-receives-patient-impact-award-from-life-sciences-pa\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/neurostar-advanced-therapy-receives-patient-impact-award-from-life-sciences-pa\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODc4OTI5NSM1NDY0NzM1IzIxMTA0NDA=\",\"datePublished\":\"2023-03-16T12:59:04+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/neurostar-advanced-therapy-receives-patient-impact-award-from-life-sciences-pa\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/neurostar-advanced-therapy-receives-patient-impact-award-from-life-sciences-pa\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/neurostar-advanced-therapy-receives-patient-impact-award-from-life-sciences-pa\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODc4OTI5NSM1NDY0NzM1IzIxMTA0NDA=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODc4OTI5NSM1NDY0NzM1IzIxMTA0NDA=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/neurostar-advanced-therapy-receives-patient-impact-award-from-life-sciences-pa\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"NeuroStar\u00ae Advanced Therapy Receives Patient Impact Award from Life Sciences PA\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"NeuroStar\u00ae Advanced Therapy Receives Patient Impact Award from Life Sciences PA - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/neurostar-advanced-therapy-receives-patient-impact-award-from-life-sciences-pa\/","og_locale":"en_US","og_type":"article","og_title":"NeuroStar\u00ae Advanced Therapy Receives Patient Impact Award from Life Sciences PA - Market Newsdesk","og_description":"Award recognizes NeuroStar for its significant contributions toward patient wellbeing MALVERN, Pa., March 16, 2023 (GLOBE NEWSWIRE) — Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohealth disorders, is named a recipient of Life Sciences Pennsylvania\u2019s (LSPA) annual\u00a0Patient Impact Award\u00a0for 2022. \u201cWe are honored that Life Sciences Pennsylvania has identified NeuroStar as a recipient of the Patient Impact Award,\u201d said Keith J. Sullivan, President and CEO of Neuronetics. \u201cWe take pride in positively impacting the lives of individuals suffering from depression and other mental health conditions. We believe they deserve a safe, effective, and non-invasive treatment option when traditional antidepressant … Continue reading \"NeuroStar\u00ae Advanced Therapy Receives Patient Impact Award from Life Sciences PA\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/neurostar-advanced-therapy-receives-patient-impact-award-from-life-sciences-pa\/","og_site_name":"Market Newsdesk","article_published_time":"2023-03-16T12:59:04+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc4OTI5NSM1NDY0NzM1IzIxMTA0NDA=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/neurostar-advanced-therapy-receives-patient-impact-award-from-life-sciences-pa\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/neurostar-advanced-therapy-receives-patient-impact-award-from-life-sciences-pa\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"NeuroStar\u00ae Advanced Therapy Receives Patient Impact Award from Life Sciences PA","datePublished":"2023-03-16T12:59:04+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/neurostar-advanced-therapy-receives-patient-impact-award-from-life-sciences-pa\/"},"wordCount":484,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/neurostar-advanced-therapy-receives-patient-impact-award-from-life-sciences-pa\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc4OTI5NSM1NDY0NzM1IzIxMTA0NDA=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/neurostar-advanced-therapy-receives-patient-impact-award-from-life-sciences-pa\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/neurostar-advanced-therapy-receives-patient-impact-award-from-life-sciences-pa\/","name":"NeuroStar\u00ae Advanced Therapy Receives Patient Impact Award from Life Sciences PA - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/neurostar-advanced-therapy-receives-patient-impact-award-from-life-sciences-pa\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/neurostar-advanced-therapy-receives-patient-impact-award-from-life-sciences-pa\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc4OTI5NSM1NDY0NzM1IzIxMTA0NDA=","datePublished":"2023-03-16T12:59:04+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/neurostar-advanced-therapy-receives-patient-impact-award-from-life-sciences-pa\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/neurostar-advanced-therapy-receives-patient-impact-award-from-life-sciences-pa\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/neurostar-advanced-therapy-receives-patient-impact-award-from-life-sciences-pa\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc4OTI5NSM1NDY0NzM1IzIxMTA0NDA=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc4OTI5NSM1NDY0NzM1IzIxMTA0NDA="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/neurostar-advanced-therapy-receives-patient-impact-award-from-life-sciences-pa\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"NeuroStar\u00ae Advanced Therapy Receives Patient Impact Award from Life Sciences PA"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/740726","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=740726"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/740726\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=740726"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=740726"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=740726"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}